The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient
Open accessAbstract
Invasive pulmonary aspergillosis is a complication in critically ill patients with acute respiratory distress syndrome, especially those with severe influenza pneumonia. We report a fatal case of invasive pulmonary aspergillosis in an immunocompetent patient in France who had severe coronavirus disease-associated pneumonia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“at the time of writing there are an increasing number of reports from Europe of patients with probable or possible COVID-19 associated pulmonary aspergillosis.50, 51, 52, 53, 54”
From Co-infections in people with COVID-19: a systematic review and meta-analysis. (2020) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171
Clinical and virological data of the first cases of COVID-19 in Europe: a case series
Lescure, F.-X., Bouadma, L., Nguyen, D. T., Parisey, M., Wicky, P.-H., Behillil, S., Gaymard, A., Bouscambert‐Duchamp, M., Donati, F., Hingrat, Q. L., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30200-0 · Cited by 1,103
Schauwvlieghe, A. F. A. D., Rijnders, B. J. A., Philips, N., Verwijs, R., Vanderbeke, L., Van Tienen, C., Lagrou, K., Verweij, P. E., Van de Veerdonk, F. L., Gommers, D., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30274-1 · Cited by 886
A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients
Blot, S. I., Taccone, F. S., den Abeele, A. V., Bulpa, P., Meersseman, W., Brusselaers, N., Dimοpoulos, G., Paiva, J. A., Misset, B., Rello, J., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-1978oc · Cited by 636
Pulmonary pathology of severe acute respiratory syndrome in Toronto
Hwang, D. M., Chamberlain, D. W., Poutanen, S. M., Low, D. E., Asa, S. L., & Butany, J. (2005) · Modern Pathology · doi:10.1038/modpathol.3800247 · Cited by 332
Schwartz, I. S., Friedman, D. Z. P., Zapernick, L., Dingle, T. C., Lee, N. L. S., Sligl, W., Zelyas, N. J., & Smith, S. W. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa007 · Cited by 102
Imbert, S., Meyer, I., Palous, M., Brossas, J., Uzunov, M., Touafek, F., Gay, F., Trosini-Desert, V., & Fekkar, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01877 · Cited by 52
Toda, M., Beekmann, S. E., Polgreen, P. M., Chiller, T. M., Jackson, B. R., & Beer, K. D. (2020) · Emerging infectious diseases · doi:10.3201/eid2604.190953 · Cited by 12
Cited by
Sorted by citations
Co-infections in people with COVID-19: a systematic review and meta-analysis.
Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.046 · Cited by 1,619
White, P. L., Dhillon, R., Cordey, A., Hughes, H. C., Faggian, F., Soni, S., Pandey, M. K., Whitaker, H., May, A., Morgan, M. P. G., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1298 · Cited by 446
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
Arastehfar, A. A., Carvalho, A., van de Veerdonk, F. L., Jenks, J. D., Koehler, P. A., Krause, R., Cornely, O. A., Perlin, D. S., Lass‐Flörl, C., & Hoenigl, M. (2020) · Journal of Fungi · doi:10.3390/jof6020091 · Cited by 427
COVID-19–associated Pulmonary Aspergillosis
van Arkel, A., Rijpstra, T. A., Belderbos, H. N. A., van Wijngaarden, P., Verweij, P. E., & Bentvelsen, R. G. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-1038le · Cited by 379
COVID-19–Associated Pulmonary Aspergillosis, March–August 2020
Salmanton‐García, J., Sprute, R., Stemler, J., Bartoletti, M., Dupont, D., Valerio, M., García‐Vidal, C., Falces‐Romero, I., Machado, M., de la Villa, S., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2704.204895 · Cited by 270
Metadata
- Authors
- Blaize, M., Mayaux, J., Nabet, C., Lampros, A., Marcelin, A.-G., Thellier, M., Piarroux, R., Demoule, A., & Fekkar, A.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Sorbonne Université (FR)
- Corresponding author
- Fekkar, Arnaud
- ORCID
- Venue
- Emerging infectious diseases
- Published
- 2020-07
- Volume
- 26
- Issue
- 7
- Pages
- 1636-1637
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- PMC
- PMC7323532
- OpenAlex
- W3018955529
- Cited by
- 142
- References
- 10
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 7 · 2023: 13 · 2022: 20 · 2021: 45 · 2020: 52
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Emerging infectious diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- invasive pulmonary aspergillosis, COVID-19 pandemic, coronavirus disease, COVID-19 pneumonia, immunocompetent patient, acute respiratory distress syndrome, critically ill patients, opportunistic fungal infection, fatal outcome
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Aged, Humans, Immunocompetence, Male, Pneumonia, Viral, Coronavirus Infections, Pulmonary Aspergillosis, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
